Medical News

RSS

USPTO issues Notice of Allowance for INSORB Skin Closure technology

Incisive Surgical, Inc. today announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for another key patent application, "Mechanical Method and Apparatus for Tissue Fastening." The allowed claims include subject matter covering the method of the INSORB Skin Closure technology and specific stapler features.

28 Sep 2010

ManagementPlus' EHR 5.0 software achieves CCHIT certification

On the heels of its pre market and ePrescribing conditional CCHIT certification, ManagementPlus' electronic health record software, ManagementPlus EHR 5.0, has now achieved full certification for its product, CCHIT Certified 2011 Ambulatory EHR.

28 Sep 2010

Endo Pharmaceuticals to acquire Qualitest Pharmaceuticals

Endo Pharmaceuticals announced today that it has entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.

28 Sep 2010

Kindred Healthcare completes acquisition of nursing and rehabilitation centers in Dallas-Fort Worth market

Kindred Healthcare, Inc. today announced that its subsidiaries have completed the previously announced acquisition of three nursing and rehabilitation centers in the Dallas-Fort Worth market for a purchase price of $38 million in cash. The Company financed this transaction with proceeds from its revolving credit facility.

28 Sep 2010

Portable humidifiers may reduce airborne influenza virus: Study

A new scientific study published in the open access, peer-reviewed journal Environmental Health indicates that the use of portable humidifiers in the home may reduce the survival of airborne influenza virus by controlling humidity indoors.

28 Sep 2010

Intellidose expert to moderate a panel of EMR champions at ACCC

The economics of private oncology practices have fundamentally changed in the past three years - driving practice consolidation, specialty diversification, and hospital affiliations. While dealing with these external pressures, oncology practices also need to automate key practice processes with technology - and plan that investment wisely in expectation of continued change.

28 Sep 2010

PharMerica signs asset purchase agreement to acquire Chem Rx Corporation

PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today announced that it has signed an asset purchase agreement to acquire substantially all of the assets of Chem Rx Corporation for $70.6 million.

28 Sep 2010

Health Council of Canada releases report on how physicians' decisions affect healthcare services in Canada

A report released today by the Health Council of Canada, Decisions, Decisions: Family Doctors as Gatekeepers to Prescription Drugs and Diagnostic Imaging in Canada, calls for better management of prescription drugs and diagnostic imaging services in this country.

28 Sep 2010

Optogenetics helps to restore optimal movement in people with physical disabilities

Researchers at Stanford University were able to use light to induce normal patterns of muscle contraction, in a study involving bioengineered mice whose nerve-cell surfaces are coated with special light-sensitive proteins.

28 Sep 2010

Galapagos initiates phase II clinical study of GLPG0259 drug in RA patients

Galapagos NV announced today that it has started a Phase II clinical study for the Company's flagship program GLPG0259, a novel drug being developed for rheumatoid arthritis. In this clinical trial, the safety and efficacy of this novel candidate drug will be tested in RA patients. Galapagos plans to announce interim results by the middle of next year and complete the trial by the end of 2011.

28 Sep 2010

Cintas’s new white paper offers EVS tips to reduce hospital-acquired infections

Cintas Corporation today announced the availability of a new white paper that offers Environmental Service Directors (EVS) tips to improve the handling of cleaning materials to reduce hospital-acquired infections (HAIs).

28 Sep 2010

Trimeris, Roche collaborate to commercialize FUZEON product

Trimeris, Inc., announced today that the Company and its partner, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., have entered into an agreement relieving Trimeris of any obligation to repay certain deferred marketing expenses.

28 Sep 2010

Study confirms Artelon Cosmetic can treat patients with tissue defects

A post-market study has been conducted by the Brånemark Clinic in Gothenburg on Artelon Cosmetic for soft tissue augmentation in the upper jaw. The study confirms that patients with tissue defects can be treated successfully with Artelon Cosmetic.

28 Sep 2010

GATC Biotech to apply Illumina's HiSeq 2000 for human genome analysis

Within the next four years GATC Biotech plans to analyse 100,000 human genomes in particular for the pharmaceutical and diagnostic industry as well as for academic research. This will be realised by applying Illumina's HiSeq 2000 as well as GATC Biotech's latest acquisition, the single molecule sequencing platform PacBio RS.

28 Sep 2010

GenMark’s eSensor technology selected for Warfarin clinical study

GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that their eSensor Warfarin Sensitivity Test has been selected for use in a new pivotal Warfarin clinical study the WARFARIN Trial.

28 Sep 2010

HCC report supports implementation of medical imaging guidelines for physicians

The Canadian Association of Radiologists (CAR) recently contributed to a report produced by the Health Council of Canada (HCC) entitled “Decisions, Decisions: Family Doctors as Gatekeepers in the Use of Prescription Drugs and Diagnostic Imaging in Canada.” This report, which was released today, supports one of the CAR’s main objectives: to implement medical imaging guidelines at a national level to guide physicians in selecting the most effective diagnostic imaging exam the first time.

28 Sep 2010

SORT-OUT IV trial compares XIENCE V, CYPHER Stent in major acute coronary events

Investigators reported results of SORT-OUT IV, comparing Cordis Corporation's CYPHER Sirolimus-eluting Coronary Stent and Abbott's XIENCE V Everolimus-eluting Stent in the primary endpoint of MACE (major acute coronary events) at nine months.

28 Sep 2010

ETP Nanomedicine forum to take place in Italy on 14 and 15 October 2010

The 5th General Assembly & Annual Forum of the European Technology Platform on Nanomedicine will take place at Centro Congressi Fondazione Cariplo in Milan, Italy on 14 and 15 October 2010.

28 Sep 2010

Study establishes link between swearing and pain tolerance

While swearing is often a common response to pain, Richard Stephens and his colleagues, John Atkins and Andrew Kingston, were surprised to discover that no links had been established between swearing and the actual experience of physical pain.

28 Sep 2010

Venous thromboembolism drugs to experience robust growth by 2019

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven primarily by the launch and widespread uptake of novel oral anticoagulants, the combined markets for drugs used in the treatment and prophylaxis of venous thromboembolism will experience robust growth, increasing from $2.9 billion in 2009 to more than $5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

28 Sep 2010